共 50 条
- [1] ADRIAMYCIN (NSC-123127) CARDIOMYOPATHY [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 203 - 208
- [2] RATIONAL BASES FOR ADRIAMYCIN (NSC-123127) COMBINATION THERAPY [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 227 - 230
- [3] ADRIAMYCIN (NSC-123127) PHARMACOLOGY [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 153 - 158
- [4] CLINICAL PHARMACOLOGY OF ADRIAMYCIN (NSC-123127) [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 183 - 185
- [5] CARDIOTOXICITY OF ADRIAMYCIN (NSC-123127) IN CHILDREN [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 209 - 214
- [6] ADRIAMYCIN (NSC-123127) BY ARTERIAL INFUSION [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 187 - 189
- [7] ADRIAMYCIN (NSC-123127) - THOUGHTS FOR FUTURE [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 389 - 397
- [8] ADRIAMYCIN (NSC-123127) IN PEDIATRIC MALIGNANCIES [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 259 - 266
- [9] ADRIAMYCIN (NSC-123127) AND ITS ANALOGS [J]. CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1974, 4 (04): : 5 - 9
- [10] RESPONSE OF METASTATIC MALIGNANT CARCINOID TUMOR TO ADRIAMYCIN (NSC-123127) [J]. CANCER TREATMENT REPORTS, 1976, 60 (03): : 273 - 276